NCT04403724View on ClinicalTrials.gov

Sequential and Mixture Injection of Opioids and Hyperbaric Bupivacaine

PHASE4CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

July 11, 2020

Primary Completion Date

March 17, 2021

Study Completion Date

March 17, 2021

Conditions
Bupivacaine Adverse ReactionRegional Anesthesia MorbidityCesarean Section Complications
Interventions
DRUG

Bupivacaine-fentanyl-Morphine.

2.4 ml Bupivacaine 0.5%, 20 µg Fentanyl and, 100 µg preservative free morphine

Trial Locations (1)

11111

Assiut University hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT04403724 - Sequential and Mixture Injection of Opioids and Hyperbaric Bupivacaine | Biotech Hunter | Biotech Hunter